Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Interstitial Lung Disease
2024 Standout
Works of Charles Asare being referenced
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Charles Asare | 147 | 54 | 17 | 293 | 220 | 4 | 490 | |
| Renata Martincova | 168 | 80 | 39 | 185 | 186 | 8 | 434 | |
| A.J. Frew | 44 | 30 | 1 | 362 | 161 | 8 | 533 | |
| Ashraf Uzzaman | 94 | 55 | 12 | 211 | 151 | 9 | 506 | |
| G. Hense | 24 | 21 | 8 | 235 | 342 | 6 | 564 | |
| Chris Kell | 33 | 53 | 2 | 292 | 154 | 7 | 415 | |
| Hirohita Kita | 81 | 115 | 4 | 437 | 209 | 7 | 521 | |
| Shih‐Ying Wu | 81 | 51 | 9 | 117 | 150 | 9 | 416 | |
| Dylan Birchard | 53 | 92 | 11 | 272 | 154 | 4 | 433 | |
| Jeanne Allinne | 53 | 91 | 11 | 268 | 153 | 5 | 430 | |
| Barry P. Sandall | 16 | 37 | 24 | 155 | 224 | 6 | 486 |
All Works
Loading papers...